mianserin has been researched along with Kidney Failure, Chronic in 4 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tacrolimus blood levels were higher than 15 ng/ml." | 5.35 | Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant. ( Alvarez, M; Corbacho, L; Fraile, P; Garcia, T; Garcia-Cosmes, P; Tabernero, JM, 2009) |
| "An 83-year-old man with chronic renal failure was referred to our hospital because of subacute progressive right hemiparesis." | 1.43 | A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy. ( Asayama, S; Asayama, T; Kosaka, S; Nakamichi, K; Ohnuki, E; Saijo, M, 2016) |
| "Tacrolimus blood levels were higher than 15 ng/ml." | 1.35 | Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant. ( Alvarez, M; Corbacho, L; Fraile, P; Garcia, T; Garcia-Cosmes, P; Tabernero, JM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohnuki, E | 1 |
| Asayama, S | 1 |
| Asayama, T | 1 |
| Nakamichi, K | 1 |
| Saijo, M | 1 |
| Kosaka, S | 1 |
| Fraile, P | 1 |
| Garcia-Cosmes, P | 1 |
| Garcia, T | 1 |
| Corbacho, L | 1 |
| Alvarez, M | 1 |
| Tabernero, JM | 1 |
| Rodriguez-Pecci, MS | 1 |
| Fuente-Aguado, Jde L | 1 |
| Montero-Tinnirello, J | 1 |
| Fernandez-Fernandez, FJ | 1 |
| Kennedy, SH | 1 |
| Craven, JL | 1 |
| Rodin, GM | 1 |
| Roin, GM | 1 |
1 trial available for mianserin and Kidney Failure, Chronic
| Article | Year |
|---|---|
Major depression in renal dialysis patients: an open trial of antidepressant therapy.
Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Desipramine; Humans; Kid | 1989 |
3 other studies available for mianserin and Kidney Failure, Chronic
| Article | Year |
|---|---|
A case of progressive multifocal leukoencephalopathy with chronic renal failure, whose JC virus in cerebrospinal fluid disappeared after mefloquine-mirtazapine dual therapy.
Topics: Aged, 80 and over; Astrocytes; Brain; Cerebrospinal Fluid; Drug Therapy, Combination; Humans; Immuno | 2016 |
Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant.
Topics: Aged; Antidepressive Agents, Tricyclic; Blood Pressure; Depressive Disorder; Drug Interactions; Fema | 2009 |
[Mirtazapine-associated hepatotoxicity].
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressive Disorder; Dru | 2010 |